Bladder cancer

A malignant tumor of the bladder is a dangerous and often fatal neoplasm that initially originates from the mucous membrane of the bladder and can affect both organs located near the bladder and distant ones.

The most dangerous are malignant tumors of the urinary bladder - papillary and infiltrating cancer. According to statistics, men develop them four times more often than women. The most at risk age group is 40-60 years old.

Bladder cancer risk factors

The etiology of bladder cancer is not well understood. But it can be argued with confidence that the risk of its development is associated with smoking and exposure to various chemical or biological carcinogens. It depends on the structural features of the organ. The bladder performs an accumulative function, so products dissolved in urine can affect its walls for some time.

Previous radiation therapy, which was used, for example, in the treatment of ureteral cancer, can also become the cause of the development of a malignant tumor.

Malignant neoplasm can develop in the presence of chronic cystitis or a parasitic lesion - schistosomiasis.

In addition, there are:

  • smoking;
  • age over 40;
  • genetic predisposition.

Bladder cancer symptoms and diagnosis

The primary symptom of bladder cancer is blood in the urine. No pain is observed in this case. This symptom does not always mean exactly oncological problems, but you cannot hesitate and you need to urgently sign up for a diagnosis with a urologist.

If the tumor has already grown deep into the bladder wall, then it can cause compression of the ureters. This will lead to the development of kidney failure. In this case, the patient may begin to experience pain in the lumbar region. But correct diagnosis is important here. Similar symptoms are seen in kidney cancer.

With the progression of the disease and the absence of proper treatment, others join the symptoms described above:

  • difficult, often painful urination;
  • pain in the lower abdomen that radiates to the perineum;
  • urge to urinate.

Examination of the patient begins with examination and palpation. However, bladder tumors are usually not palpable. Next, a number of laboratory tests are assigned:

  • urinalysis for the presence of red blood cells;
  • bacteriological culture, necessary to exclude infection in the urinary tract;
  • biochemical blood test showing the level of nitrogenous bases;
  • tumor markers.

Instrumental diagnostics is required. The patient needs to undergo ultrasound, MRI, MSCT, cystoscopy. Ultrasound examination can detect tumors larger than 1 cm. Magnetic tomography is necessary to determine the stage of the disease and the involvement of the lymph nodes. During cystoscopy, tumor particles can be taken for biopsy. This allows you to determine the nature of the neoplasm. If there is a suspicion of bone metastases, then an additional radiological examination is performed.

Treatment

The choice of treatment method depends on the stage of the disease; it is determined by the size of the tumor, the degree of its invasion into the bladder membrane, damage to the internal organs and the lymphatic system.

Treatment for bladder cancer may include surgery, drug therapy, and radiation therapy. The individual treatment regimen depends on the stage of the disease.

If the tumor does not affect the muscle layer and is "superficial", then transurethral resection is used. It is performed using a minimally invasive endoscopic method. After the procedure, the patient is prescribed a course of chemotherapy or immunotherapy. This is necessary to reduce the risk of disease recurrence.

If the tumor has penetrated into the muscle layer, then a course of radiation therapy is prescribed or a more radical surgical intervention is performed. The bladder is removed and an analogue from the colon segment is created to replace it.

External beam radiation therapy and chemotherapy can be an adjunct to treatment.

Service record



Specialists

All specialists
Merkulov
Igor Alexandrovich

Deputy chief physician for oncology, oncologist

Doctor of Sciences, PhD


Academician, professor, Doctor of Sciences, PhD

Petrov
Dmitry Yurevich

Deputy chief physician for oncology, surgeon

PhD, Docent

Ershova
Ksenia Igorevna

Head of department, oncologist

PhD

Rasner
Pavel Ilyich

Consultant in urology, urologist

Doctor of Sciences, PhD, professor

Malygin
Sergey Evgenyevich

Oncologist-mammologist, surgeon

Pshikhachev
Ahmed Mukhamedovich

Urologist, Oncologist

Doctor of Sciences, PhD

Shevchuk
Alexei Sergeyevich

Oncogynecology consultant, obstetrician-gynecologist

PhD

Chichkanova
Tatyana Vladimirovna

Oncologist-mammologist, radiologist

Katz
Ksenia Vladimirovna

Dermatovenerologist, oncologist

Rakova
Elena Sergeevna

Oncologist, chemotherapist

Udin
Oleg Ivanovich

Deputy chief physician for surgery, surgeon

PhD

Kogonia
Lali Mikhailovna

Chemotherapist

Doctor of Sciences, PhD

Ushenina
Maria Valerievna

Oncologist-chemotherapist

PhD

Stepura
Yulia Evgenievna

Head of the department of antitumor drug therapy, oncologist, chemotherapist

Volkova
Daria Mikhailovna

Head of the radiation therapy department

Gomov
Mikhail Alexandrovich

Consultant in oncogynecology, obstetrician-gynecologist

Grishin
Igor Igorevich

Obstetrician-gynecologist

Doctor of Sciences, PhD, professor

Achba
Maya Otarovna

Radiologist, ultrasound diagnostician, oncologist-mammologist